Exchange Traded Concepts’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,055
| Closed | -$119K | – | 1417 |
|
|
2025
Q1 | $119K | Sell |
6,055
-1,428
| -19% | -$28.1K | ﹤0.01% | 1088 |
|
|
2024
Q4 | $168K | Hold |
7,483
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q3 | $191K | Sell |
7,483
-11,350
| -60% | -$290K | ﹤0.01% | 979 |
|
|
2024
Q2 | $440K | Sell |
18,833
-5,858
| -24% | -$137K | 0.01% | 721 |
|
|
2024
Q1 | $434K | Buy |
24,691
+15,983
| +184% | +$281K | 0.01% | 667 |
|
|
2023
Q4 | $121K | Buy |
8,708
+2,208
| +34% | +$30.6K | ﹤0.01% | 865 |
|
|
2023
Q3 | $88.8K | Sell |
6,500
-434
| -6% | -$5.93K | ﹤0.01% | 944 |
|
|
2023
Q2 | $142K | Buy |
+6,934
| New | +$142K | ﹤0.01% | 859 |
|